Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transarterial Chemoperfusion in Unresectable Pleural Mesothelioma
NCT02611037Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Mar 2016
- Primary completion
- Oct 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, methotrexate, gemcitabine in malignant pleural mesothelioma (MPM), sponsored by Moffitt Cancer Center. Started Mar 2016; status: completed.
02
Drugs
cisplatinmethotrexategemcitabine
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT02611037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02611037.